annual operating expenses:
$375.68M+$29.98M(+8.67%)Summary
- As of today (September 17, 2025), PCRX annual total operating expenses is $375.68 million, with the most recent change of +$29.98 million (+8.67%) on December 31, 2024.
- During the last 3 years, PCRX annual operating expenses has risen by +$120.79 million (+47.39%).
- PCRX annual operating expenses is now at all-time high.
Performance
PCRX Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$131.10M+$4.66M(+3.69%)Summary
- As of today (September 17, 2025), PCRX quarterly total operating expenses is $131.10 million, with the most recent change of +$4.66 million (+3.69%) on June 30, 2025.
- Over the past year, PCRX quarterly operating expenses has increased by +$28.31 million (+27.55%).
- PCRX quarterly operating expenses is now at all-time high.
Performance
PCRX quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PCRX Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.7% | +27.6% |
| 3 y3 years | +47.4% | +24.1% |
| 5 y5 years | +37.7% | +122.5% |
PCRX Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +47.4% | at high | +38.0% |
| 5 y | 5-year | at high | +48.5% | at high | +122.5% |
| alltime | all time | at high | +1423.5% | at high | +2219.1% |
PCRX Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $131.10M(+3.7%) |
| Mar 2025 | - | $126.44M(+7.3%) |
| Dec 2024 | $375.68M(+8.7%) | $117.83M(+9.3%) |
| Sep 2024 | - | $107.76M(+4.8%) |
| Jun 2024 | - | $102.79M(-1.7%) |
| Mar 2024 | - | $104.59M(+5.0%) |
| Dec 2023 | $345.70M(+1.9%) | $99.59M(-3.4%) |
| Sep 2023 | - | $103.10M(+5.2%) |
| Jun 2023 | - | $98.00M(-4.2%) |
| Mar 2023 | - | $102.31M(+6.8%) |
| Dec 2022 | $339.31M(+33.1%) | $95.80M(+0.8%) |
| Sep 2022 | - | $95.01M(-10.0%) |
| Jun 2022 | - | $105.61M(+5.4%) |
| Mar 2022 | - | $100.19M(+33.0%) |
| Dec 2021 | $254.89M(+0.8%) | $75.32M(+22.7%) |
| Sep 2021 | - | $61.40M(-6.0%) |
| Jun 2021 | - | $65.35M(-1.5%) |
| Mar 2021 | - | $66.37M(-5.4%) |
| Dec 2020 | $252.94M(-7.3%) | $70.13M(+1.4%) |
| Sep 2020 | - | $69.18M(+17.4%) |
| Jun 2020 | - | $58.93M(-5.8%) |
| Mar 2020 | - | $62.57M(-17.5%) |
| Dec 2019 | $272.90M(+20.8%) | $75.84M(+4.8%) |
| Sep 2019 | - | $72.35M(+5.3%) |
| Jun 2019 | - | $68.72M(+11.4%) |
| Mar 2019 | - | $61.69M(+4.9%) |
| Dec 2018 | $225.85M(+6.7%) | $58.82M(-0.4%) |
| Sep 2018 | - | $59.08M(+4.6%) |
| Jun 2018 | - | $56.49M(-3.6%) |
| Mar 2018 | - | $58.57M(+19.0%) |
| Dec 2017 | $211.68M | $49.21M(-6.1%) |
| Sep 2017 | - | $52.42M(-10.3%) |
| Jun 2017 | - | $58.41M(-0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $58.75M(+13.5%) |
| Dec 2016 | $191.19M(+14.0%) | $51.74M(+12.3%) |
| Sep 2016 | - | $46.07M(-13.1%) |
| Jun 2016 | - | $53.03M(+11.8%) |
| Mar 2016 | - | $47.45M(-6.4%) |
| Dec 2015 | $167.71M(+33.7%) | $50.71M(+23.1%) |
| Sep 2015 | - | $41.20M(+7.3%) |
| Jun 2015 | - | $38.40M(+2.7%) |
| Mar 2015 | - | $37.40M(+7.1%) |
| Dec 2014 | $125.39M(+49.2%) | $34.91M(+6.9%) |
| Sep 2014 | - | $32.64M(+8.6%) |
| Jun 2014 | - | $30.05M(+8.1%) |
| Mar 2014 | - | $27.79M(+11.1%) |
| Dec 2013 | $84.07M(+49.5%) | $25.01M(+17.5%) |
| Sep 2013 | - | $21.28M(+12.4%) |
| Jun 2013 | - | $18.94M(+0.5%) |
| Mar 2013 | - | $18.84M(+13.5%) |
| Dec 2012 | $56.24M(+60.5%) | $16.61M(+11.4%) |
| Sep 2012 | - | $14.90M(+21.3%) |
| Jun 2012 | - | $12.29M(-1.3%) |
| Mar 2012 | - | $12.45M(+33.4%) |
| Dec 2011 | $35.03M(+42.1%) | $9.33M(-0.0%) |
| Sep 2011 | - | $9.33M(+3.1%) |
| Jun 2011 | - | $9.05M(+23.7%) |
| Mar 2011 | - | $7.32M(+20.1%) |
| Dec 2010 | $24.66M(-21.1%) | $6.09M(-17.8%) |
| Sep 2010 | - | $7.41M(+27.0%) |
| Jun 2010 | - | $5.83M(+3.2%) |
| Mar 2010 | - | $5.65M(-34.4%) |
| Dec 2009 | $31.25M(-25.3%) | $8.62M(+20.3%) |
| Sep 2009 | - | $7.16M |
| Dec 2008 | $41.83M(+68.4%) | - |
| Dec 2007 | $24.84M | - |
FAQ
- What is Pacira BioSciences, Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual operating expenses year-on-year change?
- What is Pacira BioSciences, Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly operating expenses year-on-year change?
What is Pacira BioSciences, Inc. annual total operating expenses?
The current annual operating expenses of PCRX is $375.68M
What is the all time high annual operating expenses for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual total operating expenses is $375.68M
What is Pacira BioSciences, Inc. annual operating expenses year-on-year change?
Over the past year, PCRX annual total operating expenses has changed by +$29.98M (+8.67%)
What is Pacira BioSciences, Inc. quarterly total operating expenses?
The current quarterly operating expenses of PCRX is $131.10M
What is the all time high quarterly operating expenses for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly total operating expenses is $131.10M
What is Pacira BioSciences, Inc. quarterly operating expenses year-on-year change?
Over the past year, PCRX quarterly total operating expenses has changed by +$28.31M (+27.55%)